Options Brief: Celsion Corporation

Shares of Celsion Corporation CLSN are lower on the session by 5.93%, trading at $3.17. Overall call volume is now running at 2.56x the daily average, with 8% of all calls traded being purchases on the offer. 3,087 contracts have traded on the session so far. Celsion Corporation is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.